Wie wärs mit einem neuen TERREX Posting?? Nennen wirs "THE BIG CHANCE"?

Nochmal für diejenigen, die die letzten zwei Tage verschlafen haben:

- ehemalige Explorationsfirma (Thail, Burma, AUS)
- Aufkauf von DoctorGlobal.com (z.Zt. 60% mit Nachkauf/Rückgabeoption)
- Testläufe in Neuseeland und China erfolgreich

Hier die Meldung

TERREX R. NL (www.terrex.com.au)

                             Quarterly Report - 30 September 1999

HIGHLIGHTS

Acquisition of Global Doctor Ltd

       Acquisition of a 60% interest in Global Doctor Ltd, a company which intends to participate in the
       medical industry through the provision of internet communication services to link medical services users
       with providers. The principal terms of the acquisition require the company to issue 26.25 million fully
       paid ordinary shares and to fund the first $450,000 of expenditure to develop the business.

       Mr Gavin Argyle, who was appointed to the board of the company during the quarter, has been
       appointed chief executive officer of Global Doctor and has initiated a plan for the rapid development of
       the business. Facilities are presently being completed in Perth and in two Asian cities in order to trial
       the systems.

       A successful technical trial has been completed of its video conferencing and telemedicine equipment
       from its first clinic in Chengdu, the capital of Sichuan, China. In addition, key medical and
       administrative appointments have been completed.



Mineral Exploration

       Formal granting of three Prospecting Licences in Myanmar to Terrex and its joint venture partners.



Share Issues and New Constitution

       Completion of two placements to raise a total of $1,575,000 and approval to change the status of the
       Company (from "NL" to "Limited").



ACQUISITION OF INTEREST IN GLOBAL DOCTOR LTD

In August 1999 the company announced the acquisition of a 60% interest in the capital of Global Doctor Limited ("GDL"), a
company which intends to participate in the medical industry through the provision of internet communication services to
link medical services users with providers. The principal terms of the acquisition require the company to issue 26.25
million fully paid ordinary shares ("Vendor Shares") and to fund the first $450,000 of expenditure to develop the business.
Additional terms include:-

       (i) A two year option to acquire an additional 20% of the issued capital of GDL. The consideration for
       this additional interest shall be based on an independent valuation of GDL at the time the option is
       exercised.

       (ii) A first right of refusal over the remaining 20% of GDL shares.

       (iii) The Vendor Shares will be subject to a voluntary escrow period of 12 months.

       (iv) If the software acquired by the Company pursuant to the agreement is not operating satisfactorily
       within 6 months, then one third of the Vendor Shares will be cancelled. In addition, if trials at two
       overseas sites are not satisfactorily completed within 12 months, then one third of the Vendor Shares
       will be cancelled (a total of two thirds of the Vendor Shares therefore being cancellable).

Following the completion of the acquisition of the interest in GDL, Mr Gavin Argyle was appointed a director of the
Company. Mr Argyle is CEO of GDL and is responsible for the commercialisation of GDL's business. Mr Argyle has
initiated a plan for the rapid development of the business. This presently involves the development of facilities being
completed in Perth and in two Asian cities in order to trial the systems.

GDL has successfully conducted a technical trial of its video conferencing and telemedicine equipment from its first clinic in
Chengdu, the capital of Sichuan, China. GDL has engaged clinical staff in Australia and China enabling delivery of a western
general practice service with Australian based doctors. GDL is currently in the process of seeking the necessary approvals
from the Chinese government for the Chengdu clinic. GDL proposes to set up its second clinic in Asia and GDL is in the
process of seeking the necessary government approvals, staff and offices.

 

 

Dr. Reitmeier, dem Schlingel *G*.
Viel Glück allen Mutigen!
 

 

Richtig geraten: ebB (etwas bezahlt Brief). Also ein limitierter Angebotsüberhang. War übrigens gestern Mittag das Gleiche.

Grüße

Short-Seller  

Jau, das stand bei ASC ca. 2 Wochen lang....mal sehen,
die Story fängt ja gleich gut an.

Und die geteilten Meinungen (Risikofreudige kaufen, Konservative schelten) macht mir auch Mut.

Der Briefgeber wird schon bald den Hahn zudrehen, soviel steht fest.  

wohl eng, da nicht mehr viele kaufen wollen. Aber was solls, warten wirs mal ab, wie sich die Story entwickelt.

Eins hast Du auf jeden Fall erreicht Drogo. Man beschäftigt sich mit dem Papier. Habe mir den Wert selbst auf meine Watchlist gelegt (aber nicht aus Kaufgründen).

Jetzt sollten wir aber an dieser Stelle aufhören. Es fängt wieder an langweilig zu werden.

Bye, Short-Seller  

schau einfach mal, was jetzt passiert. Denke schon, daß es sich lohnt. Sieht alles gut aus.  

Erinnerungsvermögen und den Verbreitungsgrad von ARIVA nicht überschätzen. Die Briefe sind bald weg....